Three takeaways from the report:
- CVS Caremark maintained an overall drug trend for its clients at 2.4 percent during the first three quarters of 2021.
- CVS Caremark managed an industry-low specialty drug trend of 5.8 percent.
- About 85 percent of CVS Caremark clients saw a specialty drug trend lower than 10 percent.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
